title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study",20220802T122759,https://www.benzinga.com/general/biotech/22/08/28308082/biotech-daily-trial-setback-for-eliem-therapeutics-allarity-drops-work-on-cancer-monotherapies-ax,INCY,0.105372,Neutral,0.0
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,INCY,0.013173,Neutral,0.040164
Gold Moves Higher; Medtronic Posts Upbeat Results - Medtronic  ( NYSE:MDT ) ,20241119T190920,https://www.benzinga.com/news/earnings/24/11/42071959/gold-moves-higher-medtronic-posts-upbeat-results,INCY,0.135729,Neutral,-0.002475
Nasdaq Gains 100 Points; Lowe's Earnings Beat Views - Lowe's Companies  ( NYSE:LOW ) ,20241119T170938,https://www.benzinga.com/news/earnings/24/11/42069005/nasdaq-gains-100-points-lowes-earnings-beat-views,INCY,0.134968,Neutral,-0.002467
"Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More",20241121T171300,https://www.zacks.com/stock/news/2373588/biotech-stock-roundup-sage-incy-suffer-setbacks-jazz-wins-oncology-drug-approval-more,INCY,0.197816,Neutral,-0.059307
"Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More",20241211T145500,https://www.zacks.com/stock/news/2382213/biotech-stock-roundup-bioa-down-on-study-update-qure-crdf-gain-on-study-data-more,INCY,0.19871,Somewhat-Bullish,0.26053
"Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate - Aquestive Therapeutics  ( NASDAQ:AQST ) ",20240930T182549,https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41101457/optimism-around-aquestive-as-it-moves-forward-with-severe-allergy-baldness-candidat,INCY,0.176502,Neutral,0.010465
"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",20220503T130106,https://www.benzinga.com/general/biotech/22/05/26958446/the-daily-biotech-pulse-fdas-adcomm-for-acadias-pimavanserin-review-issues-for-speros-tebipenem-a,INCY,0.093507,Neutral,4.5e-05
"Earnings Scheduled For May 3, 2022",20220503T085235,https://www.benzinga.com/news/earnings/22/05/26953640/earnings-scheduled-for-may-3-2022,INCY,0.01558,Neutral,-0.002632
